High Efficacy Treatments in MS

High Efficacy Treatments in MS

High Efficacy Treatments in MS
RestartResume
Dr. Montalban reviews therapies for treatment of patients with MS, including Fingolimod, Natalizumab, Alemtuzmab, and Cladribine.
  • Overview

    In this episode of MS Talks, Dr. Xavier Montalban reviews four of the 2nd line pharmacologic therapies for MS, including Fingolimod, Natalizumab, Alemtuzmab, and Cladribine.

  • Commercial Support

    This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.

Facebook Comments

Sign-up for the Global Neurology Academy newsletters.
Comprehensive Neurology Education.

Better education for a better you.

* Required
Optional